Part of conditioning treatment prior to allogeneic hematopoietic stem cell transplantation (alloHSCT).
Target
DNA
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01A ALKYLATING AGENTS
L01AB Alkyl sulfonates
L01AB02 Treosulfan
D07253 Treosulfan (USAN/INN)
Drug groups [BR:br08330]
Antineoplastic
DG01677 Alkylating agent
DG01721 Methanesulfonate derivative
D07253 Treosulfan
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D07253